Table 1.
Immune response desirability weighting.
Biological sample | Assay type | Assay target | Weight (1-5, 5 being most important) | Function | Rationale |
---|---|---|---|---|---|
Spleen | Cytokine bead array | IFN-γ | 5 | Maximize | IFNγ correlates with protection in humans and mice (6, 12) |
Stool | ELISA | IgA | 5 | Maximize | Fecal IgA correlates with protection in humans (5) |
Spleen | Cytokine bead array | IL-17A | 4 | Maximize | Depletion of IL-17A increases susceptibility in mice (7) |
Bone marrow | ELISpot | IgA | 3 | Maximize | Plasma cells are necessary for durable IgA mediated immunity (13) |
Bone marrow | ELISpot | IgG | 2 | Maximize | Plasma cells are necessary for durable IgG mediated immunity (13) |
Blood | ELISA | IgG | 2 | Maximize | Serum IgG antibody titers are indicative of systemic immunogenicity (14) |
Blood | ELISA | IgG2a/IgG1 ratio | 2 | Maximize | IgG2a/IgG1 ratio correlates with Th1 immunity (15) |